FDA Approves Taiho Oncology's LONSURF® (trifluridine/tipiracil) for Adult Patients with Previously Treated Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma - PRNewswire

FDA Approves Taiho Oncology's LONSURF® (trifluridine/tipiracil) for Adult Patients with Previously Treated Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma  PRNewswire

PRINCETON, N.J., Feb. 25, 2019 /PRNewswire/ -- Taiho Oncology, Inc. today announced that the United States Food and Drug Administration (FDA) has ...